Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 6
Submit an article Journal homepage
252
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Artesunate possesses anti-leukemia properties that can be enhanced by arsenic trioxide

Ying LiDepartment of Hematology, Provincial Hospital Affiliated to Shandong University, Jinan, P. R. China
,
Lili FengDepartment of Hematology, Provincial Hospital Affiliated to Shandong University, Jinan, P. R. China
,
Ying LiDepartment of Hematology, Provincial Hospital Affiliated to Shandong University, Jinan, P. R. China;Department of Diagnostics, Shandong University School of Medicine, Jinan, Shandong, P. R. China
,
Wen JiangInstitute of Immunopharmacology and Immunotherapy, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China
,
Ningning ShanDepartment of Hematology, Provincial Hospital Affiliated to Shandong University, Jinan, P. R. China
&
Xin WangDepartment of Hematology, Provincial Hospital Affiliated to Shandong University, Jinan, P. R. China;Department of Diagnostics, Shandong University School of Medicine, Jinan, Shandong, P. R. ChinaCorrespondence[email protected]
Pages 1366-1372 | Received 22 Dec 2012, Accepted 23 Jul 2013, Published online: 09 Sep 2013

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zhe Ma, Yuqi Fan, Yumei Wu, Dereje Kebebe, Bing Zhang, Peng Lu, Jiaxin Pi & Zhidong Liu. (2019) Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment. International Journal of Nanomedicine 14, pages 2029-2053.
Read now
Yongbin Ye, Xiaojun Xu, Mingwan Zhang, Dafa Qiu, Xiaochun Bai, Jing Wang, Guangyang Weng, Ruiqing Zhou, Ziwen Guo, Huiqing He, Wenfang Yi, Xin He & Kunyuan Guo. (2015) Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis. Leukemia & Lymphoma 56:11, pages 3159-3167.
Read now

Articles from other publishers (12)

Sareh Kamran, Ajantha Sinniah, Mahfoudh A. M. Abdulghani & Mohammed Abdullah Alshawsh. (2022) Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review. Cancers 14:5, pages 1100.
Crossref
Toby Ellis, Elvis Eze & Bahijja Tolulope Raimi-Abraham. (2021) Malaria and Cancer: a critical review on the established associations and new perspectives. Infectious Agents and Cancer 16:1.
Crossref
Xiulan Yang, Yudong Zheng, Lian Liu, Jiangrong Huang, Fei Wang & Jie Zhang. (2021) Progress on the study of the anticancer effects of artesunate (Review). Oncology Letters 22:5.
Crossref
R. I. Mancuso, M. A. Foglio & S. T. Olalla Saad. (2020) Artemisinin-type drugs for the treatment of hematological malignancies. Cancer Chemotherapy and Pharmacology 87:1, pages 1-22.
Crossref
Li Chen, Chao Wang, Ning Hu & Hongmian Zhao. (2019) Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells. RSC Advances 9:2, pages 1004-1014.
Crossref
Nelson Siukei Lam, Xinxin Long, Jonathan W. Wong, Robert C. Griffin & James C.G. Doery. (2019) Artemisinin and its derivatives. Anti-Cancer Drugs 30:1, pages 1-18.
Crossref
Marion Orsini, Franck Morceau, Mario Dicato & Marc Diederich. (2018) Autophagy as a pharmacological target in hematopoiesis and hematological disorders. Biochemical Pharmacology 152, pages 347-361.
Crossref
Thomas Efferth. (2017) Cancer combination therapies with artemisinin-type drugs. Biochemical Pharmacology 139, pages 56-70.
Crossref
Qingmin Gao, Jingwei Jiang, Zhaohui Chu, Hao Lin, Xinli Zhou & Xiaohua Liang. (2017) Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity. Oncology Letters 13:4, pages 2141-2150.
Crossref
Liping Wu, Yilin Pang, Guiqi Qin, Gaina Xi, Shengnan Wu, Xiaoping Wang & Tongsheng Chen. (2017) Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives. PLOS ONE 12:2, pages e0171840.
Crossref
Yunlong Li, Guopeng Yu, Qiaoxing Li, Weilu Wang, Xiangqian Shen, Hua Liu & Ruijiang Liu. (2015) Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3). PLOS ONE 10:4, pages e0124959.
Crossref
Richard E. Kast, Georg Karpel-Massler & Marc-Eric Halatsch. (2014) CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget 5:18, pages 8052-8082.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.